Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall neurontinIn June 2002 Neurontin litigation began against Pfizer, the maker of this prescription drug. Neurontin was originally developed by Parke-Davis in the early 1980s but has been manufactured by pharmaceutical giant Pfizer since 2000. Neurontin was approved by the FDA in 1983 for two uses: as an adjunct treatment for partial seizure disorder and to treat the nerve pain associated with shingles and herpes.
A drug must receive FDA approval before a pharmaceutical company can legally market their product for specific uses. Drugs may lawfully be prescribed by doctors for uses that have not been FDA approved, but the drug company cannot play a part in that decision. Off-label uses of a drug have not been evaluated for safety by the FDA and therefore may not be safe for consumers. Neurontin has been prescribed frequently for at least eleven off-label uses including, but not limited to: bipolar disorder, attention deficit disorder, migraines, drug and alcohol withdrawal seizures, and a number of pain conditions.
The 2002 Neurontin litigation professionals charged Pfizer with illegally paying doctors to prescribe Neurontin for off-label uses. This Neurontin litigation began when a whistleblower with inside knowledge of these acts came forward and reported this information to the proper authorities. During the course of this Neurontin litigation, Pfizer plead guilty to the charges that they unlawfully marketed Neurontin for off label uses. Pfizer settled the Neurontin litigation by paying $430 million in punitive damages. Following the settlement, Pfizer estimated that nearly eighty percent of Neurontin sales are for off label uses.
Neurontin litigation has also been pursued on behalf of those who have taken this medication for off label uses and those who have suffered damages as a result. Neurontin users have an increased risk of suffering a number of side effects associated with this medication. When patients are not sufficiently advised of a drug’s potential side effects and suffer losses as a result, they have the right to pursue Neurontin litigation for relief.
Neurontin side effects can include the following complications and more: sleepiness, dizziness, blurred or double vision, tumor growth, tremors, swelling of the hands and feet, gastrointestinal problems, skin sensitivity, weight gain, kidney complications, aberrant eye movements, sexual dysfunction, suicidal ideations, allergic reaction, amnesia, depression, anxiety, paranoia, aggression, thought disturbances, and sudden unexplained deaths.
If you or a loved one has experienced these, or any other, significant side effects of Neurontin, you may wish to consider Neurontin litigation. Through Neurontin litigation a victim of Neurontin side effects can seek relief for related damages including medical expenses, loss of income, and psychological suffering.
If you are interested in learning more about Neurontin litigation, you may wish to contact a qualified and knowledgeable attorney who can evaluate your case to determine your legal rights and options.
The FDA has requested 14 drugmakers to check their study data to see if use of epilepsy drugs results in suicidal behavior or thoughts, giving the drugmakers six months to respond.
Sales of anti-seizure drugs in the U.S. during 2004 were th...
Just weeks after Pfizer and its Warner-Lambert Co. unit were penalized $430 million in federal and state courts for selling Neurontin for purposes that have not yet been FDA approved, the company is again under fire for fraudulent marketing practices. ...
The world''s largest drug manufacturer, Pfizer, Inc., agreed to pay at least $400 million in order to settle civil charges regarding kickbacks to encourage doctors to prescribe the anti-epileptic drug Neurontin for other purposes.
The se...